Certara Inc (NAS:CERT)
$ 11.27 0.34 (3.11%) Market Cap: 1.81 Bil Enterprise Value: 1.83 Bil PE Ratio: 0 PB Ratio: 1.72 GF Score: 73/100

Certara Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 13, 2023 / 07:45PM GMT
Release Date Price: $14.51 (+0.97%)
Joseph D. Vruwink
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Hi, everyone. Thanks for making it to the end. We saved the best for last. I'm Joe Vruwink, the vertical software analyst at Baird, and our next presentation is from Certara. Certara is a company that is really changing and transforming the way drugs are developed, and they do that through leadership in biosimulation software (inaudible) related set of service offerings. Joining us from the company today is William Feehery, he's CEO; John Gallagher, CFO. This is going to be a fireside chat format. If anyone in the audience has questions, you can raise your hand or e-mail session2@rwbaird, then I'll get them on the tablet.

Questions & Answers

Joseph D. Vruwink;William F. Feehery
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst;Certara, Inc. - CEO & Director<

But maybe just to begin, we can get a brief overview of Certara and kind of your -- how you think about the investment case.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot